| #208 |
Brett C. Porath |
Acushnet |
1 |
| #208 |
Christopher B. Slovak |
Tealium |
1 |
| #208 |
Alexander Nicholas Pozzi |
B/E Aerospace |
1 |
| #208 |
Rachid Ouidja |
Spinal Elements |
1 |
| #208 |
Peter Lien |
Qualcomm |
1 |
| #208 |
Jin CHEN |
Gen-Probe Incorporated |
1 |
| #208 |
Eddie L. T. Choy |
Qualcomm |
1 |
| #208 |
Michael Oestergaard |
Ionis Pharmaceuticals |
1 |
| #208 |
Allan Arman KASPAR |
Novartis Ag |
1 |
| #208 |
Daniel J. Levendowski |
Advanced Brain Monitoring |
1 |
| #208 |
Kristopher Enslow |
Applied Materials |
1 |
| #208 |
Benjamin Littler |
Vertex Pharmaceuticals Incorporated |
1 |
| #208 |
Bryan Choi |
Musculoskeletal Transplant Foundation |
1 |
| #208 |
Francis Turner |
Threatstop |
1 |
| #208 |
Maciej Witkos |
— |
1 |
| #208 |
Kerry Cooke |
Morton International |
1 |
| #208 |
Daniel Bensen |
Merck |
1 |
| #208 |
Dana Ehyaei |
Taylor Made Golf Company |
1 |
| #208 |
Paul Angell |
Vertex Pharmaceuticals Incorporated |
1 |
| #208 |
Joshua Shirley |
Thermo Fisher |
1 |
| #208 |
Amand Kasimatis |
Covidien Lp |
1 |
| #208 |
Kevin HEINEMANN |
Thermo Fisher |
1 |
| #208 |
Daniel Lyle Hubbard |
Websense |
1 |
| #208 |
Stefan Westin |
Google |
1 |
| #208 |
Kevin M. McCluskey |
Intuit |
1 |
| #208 |
Tyler John Holschlag |
Alphatec Spine |
1 |
| #208 |
Bridget Davis |
Samsung |
1 |
| #208 |
Kevin Sayer |
Dexcom |
1 |
| #208 |
Eamonn Martin Kelly |
Koniniklijke Philips N.V. |
1 |
| #208 |
Stephen Moxey |
— |
1 |
| #208 |
Paul Holdaway |
Qualcomm |
1 |
| #208 |
Pooja Johari |
— |
1 |
| #208 |
Michael Anthony Borrello |
Koniniklijke Philips N.V. |
1 |
| #208 |
Sridhar Ramesh |
Maxlinear |
1 |
| #208 |
Eric J. Mathur |
Diversa |
1 |
| #208 |
Reid P. Bissonnette |
Huya Bioscience International |
1 |
| #208 |
Alexander J. Willman |
— |
1 |
| #208 |
Elizabeth F. Connor |
Viasat |
1 |
| #208 |
George Jaspert |
— |
1 |
| #208 |
Ramin Parsi |
— |
1 |
| #208 |
Ronald J. Christopher |
Arena Pharmaceuticals |
1 |
| #208 |
Len Briggs |
Boston Scientific Scimed |
1 |
| #208 |
Erik P. Johnson |
Quest Diagnostics Investments |
1 |